Alzheimer’s is the most common form of dementia and we have gone far too long without a new treatment. NeuroWellness and Dr Smalley have specialized in dementia care for many years. Dr Smalley has been engaged in clinical care and research since 1998 and he is pleased that there is finally a new drug to treat early Alzheimer’s.
We are taking new patients to assess for this new breakthrough drug, Leqembi. Leqembi has been shown to safely reduced cognitive decline and change the pathology of Alzheimer’s by attacking the toxic protofibrils.